External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: Age is not a problem

Sergio Villa, Nice Bedini, Carlo Fallai, Patrizia Olmi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The files of 183 elderly patients aged >70 years, with localized prostate cancer (T1-3, N0-X, M0), treated with radical external radiation therapy (ERT) from January 1992 to December 2001 at the Radiotherapy Department of the Istituto Nazionale Tumori of Milan, were reviewed. Median age was 75 years. ERT represented the sole treatment for 73 patients (39.9%); in 110 cases (60.1%) hormonal therapy (HT) was associated with neoadjuvant intent. Five-year overall, disease-specific and biochemical NED (bNED) survival rates were 90.2, 93.7 and 63.2%, respectively. A subset of 23 patients aged 80 years and over were analyzed and compared to 160 men aged 70-79 years. Acute toxicity and late complications were analyzed in the two groups of patients according to the RTOG scoring system. Only 10 patients (5.4%) showed grades 2-3 (G2-3) late sequelae. The results obtained in this single-institute series highlight the pivotal role of ERT in the management of clinically localized prostate cancer in the elderly.

Original languageEnglish
Pages (from-to)215-225
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume48
Issue number2
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Prostate
Adenocarcinoma
Radiotherapy
Prostatic Neoplasms
Survival Rate
Therapeutics

Keywords

  • Elderly
  • Prostate cancer
  • Radiation therapy

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma : Age is not a problem. / Villa, Sergio; Bedini, Nice; Fallai, Carlo; Olmi, Patrizia.

In: Critical Reviews in Oncology/Hematology, Vol. 48, No. 2, 11.2003, p. 215-225.

Research output: Contribution to journalArticle

@article{d23c0ecd1a3c4005aa5835f38a497b7f,
title = "External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: Age is not a problem",
abstract = "The files of 183 elderly patients aged >70 years, with localized prostate cancer (T1-3, N0-X, M0), treated with radical external radiation therapy (ERT) from January 1992 to December 2001 at the Radiotherapy Department of the Istituto Nazionale Tumori of Milan, were reviewed. Median age was 75 years. ERT represented the sole treatment for 73 patients (39.9{\%}); in 110 cases (60.1{\%}) hormonal therapy (HT) was associated with neoadjuvant intent. Five-year overall, disease-specific and biochemical NED (bNED) survival rates were 90.2, 93.7 and 63.2{\%}, respectively. A subset of 23 patients aged 80 years and over were analyzed and compared to 160 men aged 70-79 years. Acute toxicity and late complications were analyzed in the two groups of patients according to the RTOG scoring system. Only 10 patients (5.4{\%}) showed grades 2-3 (G2-3) late sequelae. The results obtained in this single-institute series highlight the pivotal role of ERT in the management of clinically localized prostate cancer in the elderly.",
keywords = "Elderly, Prostate cancer, Radiation therapy",
author = "Sergio Villa and Nice Bedini and Carlo Fallai and Patrizia Olmi",
year = "2003",
month = "11",
doi = "10.1016/j.critrevonc.2003.05.006",
language = "English",
volume = "48",
pages = "215--225",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma

T2 - Age is not a problem

AU - Villa, Sergio

AU - Bedini, Nice

AU - Fallai, Carlo

AU - Olmi, Patrizia

PY - 2003/11

Y1 - 2003/11

N2 - The files of 183 elderly patients aged >70 years, with localized prostate cancer (T1-3, N0-X, M0), treated with radical external radiation therapy (ERT) from January 1992 to December 2001 at the Radiotherapy Department of the Istituto Nazionale Tumori of Milan, were reviewed. Median age was 75 years. ERT represented the sole treatment for 73 patients (39.9%); in 110 cases (60.1%) hormonal therapy (HT) was associated with neoadjuvant intent. Five-year overall, disease-specific and biochemical NED (bNED) survival rates were 90.2, 93.7 and 63.2%, respectively. A subset of 23 patients aged 80 years and over were analyzed and compared to 160 men aged 70-79 years. Acute toxicity and late complications were analyzed in the two groups of patients according to the RTOG scoring system. Only 10 patients (5.4%) showed grades 2-3 (G2-3) late sequelae. The results obtained in this single-institute series highlight the pivotal role of ERT in the management of clinically localized prostate cancer in the elderly.

AB - The files of 183 elderly patients aged >70 years, with localized prostate cancer (T1-3, N0-X, M0), treated with radical external radiation therapy (ERT) from January 1992 to December 2001 at the Radiotherapy Department of the Istituto Nazionale Tumori of Milan, were reviewed. Median age was 75 years. ERT represented the sole treatment for 73 patients (39.9%); in 110 cases (60.1%) hormonal therapy (HT) was associated with neoadjuvant intent. Five-year overall, disease-specific and biochemical NED (bNED) survival rates were 90.2, 93.7 and 63.2%, respectively. A subset of 23 patients aged 80 years and over were analyzed and compared to 160 men aged 70-79 years. Acute toxicity and late complications were analyzed in the two groups of patients according to the RTOG scoring system. Only 10 patients (5.4%) showed grades 2-3 (G2-3) late sequelae. The results obtained in this single-institute series highlight the pivotal role of ERT in the management of clinically localized prostate cancer in the elderly.

KW - Elderly

KW - Prostate cancer

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=0242352371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242352371&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2003.05.006

DO - 10.1016/j.critrevonc.2003.05.006

M3 - Article

C2 - 14607384

AN - SCOPUS:0242352371

VL - 48

SP - 215

EP - 225

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -